Halozyme licenses its ENHANZE drug delivery technology to biopharmaceutical companies and sells its own Hylenex and XYOSTED products. It last closed at $91.35 on Nov 20, down 1.82% on the day. The next earnings report for HALO is expected around Wed, Jan 27, 2027. For the quarter ended Sep 2026, HALO reported EPS of $2.01 on revenue of $493.0M, with revenue up 39.2% from a year ago. Over its last 8 reports the stock moved an average of 8.8% the session after earnings. Over the last 12 months HALO insiders bought $0 of stock on the open market and sold $50.3M, according to SEC Form 4 filings.
AI Auto Pilots
Is HALO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold HALO.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on HALOStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
HALO · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, oversold
The stock is 23% below its 20 day and 24% below its 50 day average. It is 6% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 20), oversold. The nearest support is the Pivot S1 at $90.21, and the nearest resistance the Pivot at $91.93.
Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityHigh, 4.5%/day
Key levels
$134.0052 week high+46.7%
$113.2150 day average+23.9%
$112.2220 day average+22.8%
$104.78Swing high (Aug 11)+14.7%
$103.16100 day average+12.9%
$93.06Pivot R1+1.9%
$91.93Pivot+0.6%
$91.35Last close
$90.21Pivot S1−1.2%
$85.89200 day average−6.0%
$81.21Swing low (Jul 30)−11.1%
$61.2352 week low−33.0%
Indicators
RSI (14)
20.02
Oversold below 30
Oversold
MACD
-6.81
Below its signal line
Bearish
Stochastic
2.7
Near the bottom of its range
Oversold
ADX (14)
45.0
Strong downtrend
Williams %R
-98.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-94.1
Oversold below −100, overbought above 100
Neutral
Rate of change
−11.8%
Change over 10 sessions
Bearish
ATR (14)
$4.12
Typical daily range, 4.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 9.4%/day
Key levels
$134.0052 week high+46.7%
$113.2150 day average+23.9%
$112.2220 day average+22.8%
$104.78Swing high (Aug 11)+14.7%
$103.16100 day average+12.9%
$93.06Pivot R1+1.9%
$91.93Pivot+0.6%
$91.35Last close
$90.21Pivot S1−1.2%
$85.89200 day average−6.0%
$81.21Swing low (Jul 30)−11.1%
$61.2352 week low−33.0%
Indicators
RSI (14)
45.73
Middle of its range
Neutral
MACD
7.88
Below its signal line
Bearish
Stochastic
16.4
Near the bottom of its range
Oversold
ADX (14)
42.0
Strong downtrend
Williams %R
-98.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-50.6
Oversold below −100, overbought above 100
Neutral
Rate of change
−14.8%
Change over 10 sessions
Bearish
ATR (14)
$8.62
Typical daily range, 9.4% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for HALO
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how HALO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow HALO usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for HALOHow many large options trades hit HALO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in HALO in the last 90 days.
From SEC Form 4 filings by HALO's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HALO is in one of them and how their past HALO trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Halozyme Therapeutics
Halozyme Therapeutics is a biopharmaceutical company based in San Diego, California. It licenses its ENHANZE drug delivery technology, built on a patented enzyme, to drugmakers that want to deliver injected medicines under the skin instead of through an IV. The company also develops hyperconcentrated drug formulations and auto-injector devices with pharmaceutical partners, and it sells its own Hylenex and XYOSTED products.